Annals of the Rheumatic Diseases | ARD is an international peer-reviewed journal covering all aspects of rheumatology, including musculoskeletal conditions, arthritic disease and connective tissue disorders.

Intro Widget

Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.

ARD is an official journal of EULAR.

Free lay summaries are provided for selected research articles. You can keep up with the latest news via Twitter and Facebook.

Editor-in-Chief: Professor Josef Smolen, Medical University of Vienna, Austria
Editorial team

Impact Factor: 12.350

Authors

Annals of the Rheumatic Diseases considers unsolicited submissions of a variety of article types, including original research articles (extended and concise reports), viewpoints, and letters to the Editor.

The Author Information section provides general guidelines and requirements for specific article types.

Information is also provided on editorial policies and open access.

Impact Factor: 12.350

Author information

Submit a paper

Intro Widget

Latest Articles

Correspondence response:

Response to: ‘Letter in response to article “Imputation-based analysis of MICA alleles in the susceptibility to ankylosing spondylitis”’ by Zhou et al

Letter:

Addressing immune-related adverse events of cancer immunotherapy: how prepared are rheumatologists?

Correspondence:

Letter in response to article ‘Imputation-based analysis of MICA alleles in the susceptibility to ankylosing spondylitis’

Correspondence response:

Response to: ‘Can solid-phase assays replace immunofluorescence for ANA screening?’ by Bizzaro

Animal models:

Decreased chance of a live born child in women with rheumatoid arthritis after assisted reproduction treatment: a nationwide cohort study

Editor’s Choice

Vasculitis:

Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data

Clinical and epidemiological research:

Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial

Criteria:

Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study

Review:

Gene editing for inflammatory disorders

Clinical and epidemiological research:

Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry

Related Journals

Most Read Articles

Rheumatoid arthritis:

Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study

Recommendation:

2018 update of the EULAR recommendations for the management of Behçet’s syndrome

Recommendation:

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)

Recommendation:

2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis

Correspondence:

Paradoxical pulmonary event under tocilizumab treatment for systemic sclerosis-associated usual interstitial pneumonia

Authors